首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1536006

大麻二酚 (CBD) 市场 - 按来源（大麻、大麻）产品（油、口服、外用、分离物、栓剂）、应用（焦虑、失眠、慢性疼痛、皮肤护理、偏头痛）、给药途径、配销通路、全球预测(2024 - 2032)

Cannabidiol (CBD) Market - By Source (Hemp, Marijuana) Product (Oil, Oral, Topicals, Isolates, Suppository), Application (Anxiety, Insomnia, Chronic Pain, Skin Care, Migraine), Route of Administration, Distribution Channel, Global Forecast (2024 - 2032)

出版日期: 2024年06月20日 | 出版商:

Global Market Insights Inc. | 英文 340 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在对其潜在效益的研究和开发不断增加的推动下，全球大麻二酚 (CBD) 市场在 2024 年至 2032 年间的复合年增长率将达到 17.9%。随着科学研究不断探索 CBD 的治疗特性，包括其缓解疼痛、焦虑和睡眠障碍的潜力，消费者的兴趣正在扩大。

研究进展揭示了 CBD 在各种健康和保健产品中的新应用，从补充剂到护肤品。越来越多的证据支持 CBD 的功效和安全性，进一步增强了其市场吸引力。例如，2024 年 2 月，科罗拉多大学博尔德分校的新研究表明，富含无毒化合物 CBD 的大麻产品可能比以 THC 为主的产品更有效地缓解焦虑，并且没有相关的副作用。

此外，监管变化和对大麻衍生产品的接受度提高也导致了需求的成长。寻求开发基于 CBD 的创新解决方案的公司对研发的持续投资对于塑造市场至关重要，因为它增强了理解，扩大了应用范围，并建立了消费者对 CBD 好处的信任。这一趋势强调了 CBD 市场的动态性质及其在健康产业中不断变化的作用。

整个大麻二酚 (CBD) 产业根据来源、产品、应用、给药途径、配销通路和地区进行分类。

消息人士透露，从2024 年到2032 年，大麻领域的大麻二酚(CBD) 市场收入将实现令人称讚的复合年增长率。缓解疼痛、焦虑和焦虑的人的热门选择。消费者和研究人员越来越关注 CBD 的潜在健康益处及其在健康和医疗产品中的应用。这一趋势强调了 CBD 在更广泛的大麻市场中不断变化的作用及其作为治疗选择的吸引力。

在产品方面，从2024年到2032年，口服CBD产品将出现显着增长。日常生活中。这种给药方法可确保剂量一致，并因其易于使用和有效管理焦虑、疼痛和睡眠障碍等病症而受到青睐。消费者对口服 CBD 产品的偏好的增长是由于其感知的益处、可靠性以及高品质、经过临床测试的配方的不断扩大的可用性。随着人们对 CBD 的认识和接受度不断提高，口服 CBD 产品不断受到欢迎，刺激了市场需求。

欧洲大麻二酚(CBD) 市场从2024 年到2032 年将呈现显着的复合年增长率。障碍。欧洲各国大麻衍生 CBD 产品合法化的不断扩大正在推动市场扩张，零售和线上通路的可用性不断增加。此外，人们对 CBD 治疗效果的认识不断增强，科学研究也促进了其受欢迎程度。随着欧洲法规的发展以适应和标准化 CBD 产品，预计市场将继续呈上升趋势，反映出更广泛的接受度和需求。

产业生态系统分析
产业影响力
- 成长动力
  - CBD 不断增长的医疗应用
  - 由于政府批准，产品的采用和使用增加
  - 改变跨区域 CBD 产品核准的监管环境
  - 零售店 CBD 产品的销售增加
- 产业陷阱与挑战
  - 与 CBD 油相关的副作用
  - 市面上有假冒和合成产品
  - CBD产品成本高
  - 处方流程复杂
成长潜力分析
监管环境
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按来源划分，2021 - 2032 年

主要趋势
大麻
麻

第 6 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
油
- 全谱CBD油
- 广谱CBD油
专题
- 透皮贴剂
- 乳霜和走珠
口服
- 药片
- 胶囊
- 酊剂
CBD吸入器
栓剂
分离物
电子烟油
其他产品

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
焦虑/压力
睡眠/失眠
慢性疼痛
偏头痛
皮肤护理
癫痫发作
关节疼痛和炎症
其他应用

第 8 章：市场估计与预测：按管理途径，2021 年至 2032 年

主要趋势
口服
专题
吸入
透皮贴剂
直肠
舌下含化

第 9 章：市场估计与预测：按配销通路，2021 - 2032

主要趋势
在线的
离线
- 医院药房
- 零售店

第 10 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

Aurora Cannabis
Charlotte's Web
Canopy Growth Corporation
CV Sciences, Inc.
Endoca
Elixinol
Folium Biosciencesilray
Gaia Herbs, LLC,
GW Pharmaceuticals
Isodiol International Inc
KOI CBD
Medical Marijuana, Inc.
Medterra
NuLeaf Naturals, LLC,
Tterrapharma
Tilray
Vapen CBD

简介目录

Product Code: 4541

Global Cannabidiol (CBD) Market will witness 17.9% CAGR between 2024 and 2032, driven by rising research and development into its potential benefits. As scientific studies continue to explore CBD's therapeutic properties, including its potential for alleviating pain, anxiety, and sleep disorders, consumer interest is expanding.

Research advancements are uncovering new applications for CBD in various health and wellness products, ranging from supplements to skincare. This growing body of evidence supports CBD's efficacy and safety, further fueling its market appeal. For instance, in February 2024, new research from CU Boulder indicated that cannabis products high in the non-intoxicating compound CBD may alleviate anxiety more effectively than THC-dominant products and without the associated side effects.

Additionally, regulatory changes and increased acceptance of hemp-derived products contribute to the rising demand. The continuous investment in R&D by companies seeking to develop innovative CBD-based solutions is pivotal in shaping the market, as it enhances understanding, broadens applications, and builds consumer trust in CBD's benefits. This trend underscores the dynamic nature of the CBD market and its evolving role in the wellness industry.

The overall Cannabidiol (CBD) Industry is classified based on the source, product, application, route of administration, distribution channel, and region.

Based on source, the cannabidiol (CBD) market revenue from the marijuana segment will register a commendable CAGR from 2024 to 2032. As interest in cannabis-derived products rises, CBD has become a popular choice for those seeking relief from pain, anxiety, and other health issues without the psychoactive effects of THC. Consumers and researchers alike are increasingly drawn to CBD's potential health benefits and its applications in wellness and medical products. This trend underscores the evolving role of CBD in the broader cannabis market and its appeal as a therapeutic option.

In terms of product, the oral segment will witness an appreciable growth from 2024 to 2032. Oral CBD products, such as capsules, tinctures, and gummies, offer a convenient and discrete method for users to incorporate CBD into their daily routines. This delivery method ensures consistent dosing and is favored for its ease of use and effectiveness in managing conditions like anxiety, pain, and sleep disorders. The growth in consumer preference for oral CBD products is driven by their perceived benefits, reliability, and the expanding availability of high-quality, clinically tested formulations. As awareness and acceptance of CBD increase, oral CBD products continue to gain popularity, boosting market demand.

Europe cannabidiol (CBD) market will exhibit a notable CAGR from 2024 to 2032. European consumers are increasingly turning to CBD for its potential health benefits, including relief from anxiety, pain, and sleep disorders. The expanding legalization of hemp-derived CBD products across various European countries is driving market expansion, with increased availability in retail and online channels. Additionally, growing awareness and scientific research into CBD's therapeutic effects contribute to its popularity. As European regulations evolve to accommodate and standardize CBD products, the market is expected to continue its upward trajectory, reflecting broader acceptance and demand.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing medical applications of CBD
  - 3.2.1.2 Increasing product adoption and utilization owing to government approvals
  - 3.2.1.3 Changing regulatory landscape for approval of CBD products across region
  - 3.2.1.4 Increasing sales of CBD products in retail stores
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Side effects associated with CBD oil
  - 3.2.2.2 Counterfeit and synthetic products available in the market
  - 3.2.2.3 High cost of CBD products
  - 3.2.2.4 Complex prescription process
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Source, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Marijuana
5.3 Hemp

Chapter 6 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Oil
- 6.2.1 Full-spectrum CBD oil
- 6.2.2 Broad-spectrum CBD oil
6.3 Topicals
- 6.3.1 Transdermal patches
- 6.3.2 Creams and roll-on
6.4 Oral
- 6.4.1 Tablet
- 6.4.2 Capsules
- 6.4.3 Tinctures
6.5 CBD inhalers
6.6 Suppository
6.7 Isolates
6.8 Vape oil
6.9 Other products

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Anxiety/ stress
7.3 Sleep/insomnia
7.4 Chronic pain
7.5 Migraines
7.6 Skin care
7.7 Seizures
7.8 Joint pain & inflammation
7.9 Other applications

Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Oral
8.3 Topical
8.4 Inhalation
8.5 Transdermal patches
8.6 Rectal
8.7 Sublingual

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Online
9.3 Offline
- 9.3.1 Hospital pharmacy
- 9.3.2 Retail stores

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa